Almost half of AML sufferers with poor prognosis exhibit overexpression of PDK1 [56] and hematopoietic malignancies including AML often exhibit inactivation of PTEN and Akt activation, which is strongly correlated with poor prognosis. The gene discussed is PDK1; the disease is acute myeloid leukemia.